| abstract |
Disclosed is a new inhibitor compound as shown in general formula (I). The compound has a good kinase inhibitory activity. The compound of formula (I) can be used for preventing and/or treating diseases mediated by abnormal expression of TAM family kinase receptors and/or ligands thereof. In addition, the compound also can target a CSF1R kinase, and can be used for preventing and/or treating diseases mediated by abnormal expression of TAM family kinase receptors /and CSF1R kinase receptors and/or ligands thereof. |